Episode Details
Back to Episodes
The Fall of Theranos: Big Promises, Bigger Lies
Published 1 week ago
Description
Theranos promised to revolutionize healthcare.
The company claimed it could perform a wide range of blood tests using just a few drops of blood from a finger prick. No large needles. No multiple vials. No long waits. It was a powerful idea, and people wanted to believe it.
Hundreds of millions of dollars were invested. The company was valued in the billions. Elizabeth Holmes became a Silicon Valley icon, appeared on major stages, attracted glowing press coverage, and surrounded Theranos with powerful supporters, including high-profile investors and board members such as Henry Kissinger and George Shultz.
Then it all collapsed.
The company disappeared, investors lost hundreds of millions of dollars, patients were put at risk, and Holmes and former Theranos president Sunny Balwani were sentenced to prison.
In this episode of Reluctant Lessons, we look beyond the headlines and examine the deeper business failure behind Theranos. This is not simply a story about fraud. It is a lesson in what happens when vision outruns verification, when credibility replaces proof, and when the story becomes bigger than the truth.
The company claimed it could perform a wide range of blood tests using just a few drops of blood from a finger prick. No large needles. No multiple vials. No long waits. It was a powerful idea, and people wanted to believe it.
Hundreds of millions of dollars were invested. The company was valued in the billions. Elizabeth Holmes became a Silicon Valley icon, appeared on major stages, attracted glowing press coverage, and surrounded Theranos with powerful supporters, including high-profile investors and board members such as Henry Kissinger and George Shultz.
Then it all collapsed.
The company disappeared, investors lost hundreds of millions of dollars, patients were put at risk, and Holmes and former Theranos president Sunny Balwani were sentenced to prison.
In this episode of Reluctant Lessons, we look beyond the headlines and examine the deeper business failure behind Theranos. This is not simply a story about fraud. It is a lesson in what happens when vision outruns verification, when credibility replaces proof, and when the story becomes bigger than the truth.